Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × fludarabine × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 66 Leukemia 63 Leukemia, Lymphocytic, Chronic, B-Cell 59 Myelodysplastic Syndromes 49 Lymphoma 44 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Lymphoma, Non-Hodgkin 41 Multiple Myeloma 37 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35 Hodgkin Disease 33 Melanoma 25 Hematologic Neoplasms 23 Myeloproliferative Disorders 16 Recurrence 15 Neoplasms 15 Neoplasm Metastasis 15 Lymphoma, Follicular 14 Primary Myelofibrosis 13 Lymphoma, Mantle-Cell 13 Neoplasms, Plasma Cell 12 Lymphoma, Large B-Cell, Diffuse 12 Skin Neoplasms 11 Graft vs Host Disease 10 Burkitt Lymphoma 10 Lymphoma, B-Cell, Marginal Zone 9 Anemia, Refractory, with Excess of Blasts 9 Lymphoma, B-Cell 8 Breast Neoplasms 8 Ovarian Neoplasms 7 Leukemia, Prolymphocytic 7

Interventions

vandetanib 7 lenvatinib 5 cabozantinib 4 Sunitinib 4 Sorafenib 4 AZD 6244 3 selpercatinib 2 durvalumab 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Paclitaxel 2 Iodine-131 2 Everolimus 2 Bortezomib 2 Axitinib 2 tremelimumab 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 regorafenib 1 pralsetinib 1 ponatinib 1 perflutren 1 pazopanib 1 pasireotide 1 methyl N-acetylsibirosaminide 1 gallium 68 PSMA-11 1 fosbretabulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡